RM Pharma Consulting ApS
CVR 44193000 · Private limited company (ApS) · Active · Low risk
RM Pharma Consulting ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 2 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK 409k and a net result of DKK 115k. CEO: Rami Abdal Monem.
Bankruptcy risk for RM Pharma Consulting ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44193000
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Tjørnevej 15A
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik (711220)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 40k
- Auditor
- SleboLundstrøm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 39.6% |
| Current ratio | 88% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 2.2m | DKK 1.8m |
| Net profit | DKK 115k | DKK 376k |
| Equity | DKK 409k | DKK 416k |
| Total assets | DKK 1.0m | DKK 681k |
| Cash | DKK 353k | – |
| Short-term debt | DKK 569k | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · SleboLundstrøm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Oct 2024 – 30 Sep 2025 | 20 | ||
| 18 Jul 2023 – 30 Sep 2024 | 15 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Rami Abdal Monem | Current | |
| Owner (100%) | Rami Abdal Monem | Current | |
| Founder | Rami Abdal Monem | Current |
Address history (0 moves)
| Tjørnevej 15A, 2970 Hørsholm |
Other companies at the same address
- BambooBandits ApS Opløst
- Nord Øst Holding ApS Compulsorily dissolved
Similar companies in Hørsholm
- INTERNATIONAL WATER ENGINEERING ApS Hørsholm
- AIR FRÖHLICH ApS Hørsholm
- Engmann Consulting ApS Hørsholm
- PharmaCon Service ApS Hørsholm
- PS TECH SOURCING ApS Hørsholm
- Component 2.0 A/S Hørsholm
- Bellatriks Consulting A/S Hørsholm
- BELLATRIKS ApS Hørsholm
- SANGBERG ApS Hørsholm
- ERIKSSON HOLDING ApS Rungsted Kyst
- GENGAS HOLDING ApS Rungsted Kyst
- MGS Design & Development A/S Hørsholm
Questions and answers about RM Pharma Consulting ApS
Has RM Pharma Consulting ApS gone bankrupt?
No, RM Pharma Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of RM Pharma Consulting ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of RM Pharma Consulting ApS?
Rami Abdal Monem is the CEO of RM Pharma Consulting ApS.
Who is the auditor of RM Pharma Consulting ApS?
RM Pharma Consulting ApS most recently used SleboLundstrøm.
When was RM Pharma Consulting ApS founded?
RM Pharma Consulting ApS was founded on 18 July 2023.
What is the equity of RM Pharma Consulting ApS?
Equity was DKK 409k according to the annual report for the period ending 30 September 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.